Learn about the updated content of the 2nd Edition of our Life Sciences Research Tools ReportLOS ANGELES, CA (DeciBio – April 12th, 2011) - Today, DeciBio released the second edition of its life science research tools report (https://www.decibio.com/intelligence/).This report provides an overview of the life sciences research tools market from 2006 to 2016. Life sciences research tools companies offer instruments, reagents and services to scientists in academic, BioPharma and applied market laboratories. Top vendors include Agilent, Bio-Rad, EMD Millipore, Life Technologies, Roche, Sigma-Aldrich and Thermo Fisher.

What’s new in this second edition?

Updated content:

• Incorporated the latest trends in the life science research tools market
• Added 8 new supplies & technologies to this market, including: Structural analysis technologies (electron microscopy, NMR and X-ray systems), Spectroscopy, Label free technologies, Glassware, Liquid handling and automation, LIMS
• Added 19 pages, primarily with new analysis, and a description of our methodology and classification
• Expanded our analysis of key players in this space

Updated overall numbers:

• Updated market numbers for 2011 market size based on secondary research and latest trends
• Market growth rate generally adjusted downward given increased focus on funding sources (and economic backdrop [e.g., in Europe]) during our interview campaign
• Estimated instrument / reagent revenue contribution for 3 technologies based on interviewee feedback (Liquid chromatography, Mass spectrometry, in vivo analysis)

Reassessed market trends for:

• NGS in light of recent developments (e.g., $1,000 genome)
• dPCR given increased visibility of market players and difficulty for the opportunity to materialize (due in part to the lack of clear applications); resulted in decreased overall opportunity size
• Cell-based discovery services given continued aggressive outsourcing from BioPharma; resulted in increased growth rate estimates

Adjusted market size and growth for some markets:

• Microarrays: given identified niche opportunities
• ELISA: Decreased market size 2010/11 market size (~20%) due to identified analysis bias; accelerated growth due to faster than expected adoption of multiplex ELISA
• Adjusted market size, given expected use from interviewee feedback
• Sample preparation: Decreased market growth, given underperformance of market leader (Qiagen)

Refined instrument/reagent revenue contributions for some technologies:

• qPCR
• Laboratory supplies
• Transfection and electroporation
• Cell culture equipment

Authors: Stephane Budel, Partner at DeciBio, LLCConnect with Stephane Budel on Google+https://plus.google.com/+StephaneBudel